Arvinas (ARVN)
(Delayed Data from NSDQ)
$7.42 USD
-0.02 (-0.27%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $7.41 -0.01 (-0.13%) 7:58 PM ET
1-Strong Buy of 5 1
C Value D Growth B Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Arvinas, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ARVN 7.42 -0.02(-0.27%)
Will ARVN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ARVN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ARVN
FOLD Q2 Earnings Miss Mark, Revenues Beat on Higher Product Sales
Bausch Health Stock Falls on Q2 Earnings Miss, Revenues Beat
ARVN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Amarin's Q2 Earnings & Revenues Trump Estimates, Stock Rises
UTHR Q2 Earnings Miss Estimates, Higher Tyvaso Sales Aid Revenues Y/Y
Alkermes Q2 Earnings Beat Estimates, Proprietary Drugs Aid Sales
Other News for ARVN
Arvinas to Report Second Quarter 2025 Financial Results on August 6, 2025 | ARVN Stock News
Arvinas: A Potential 'Sum Of The Parts' Story
Arvinas (ARVN) CEO Retirement Sparks Leadership Transition
Arvinas CEO John Houston to retire
Arvinas (ARVN) CEO John Houston Announces Plans to Retire | ARVN Stock News